HIV mutation literature information.


  HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.
 PMID: 25141905       2014       Journal of the International AIDS Society
Introduction: There are two TAM pathways: type I (M41L, L210W and T215Y) and type II (D67N, K70R, T215F and K219Q/E); the former conferring higher levels of resistance and cross-resistance.
Result: A total of 35 patients had at least 1 TAM, with the following distribution: M41L (16%), D67N (15%), K70R (9%), L210W (11%), T215Y (16%), T215F (11%), K219Q (5%) and K219E (2%).


  Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia.
 PMID: 25166019       2014       PloS one
Result: The TAM2 pathway (D67N, K70R, T215F, and K219Q/E) was present in 5/22, 4/22, 8/22, 2/22 patients.


  The lysine 65 residue in HIV-1 reverse transcriptase function and in nucleoside analog drug resistance.
 PMID: 25341667       2014       Viruses
Introduction: Several mutations (the thymidine analog mutations, TAM) are required for high-level AZT resistance by excision, and include M41L, D67N, K70R, T215F or Y and K219E or Q.


  Transmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey.
 PMID: 25397495       2014       Journal of the International AIDS Society
Abstract: However, thymidine analogue resistance mutations (TAMs) determined two distinct genotypic profiles in the HIV-1 reverse transcriptase: TAM1: M41L, L210W and T215Y, and TAM2: D67N, K70R, K219E/Q, and T215F.


  Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses.
 PMID: 25397500       2014       Journal of the International AIDS Society
Table: K219E


  Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.
 PMID: 25575025       2014       Retrovirology
Table: K219E


  HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report.
 PMID: 25803373       2014       The West Indian medical journal
Abstract: Three minor protease resistant-conferring mutations (A71AT, A71V, A71T) and five mutations conferring high to low-level resistance (K219EK, T69S, K103S, G190A and K103N) were detected in the RT region.


  Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance.
 PMID: 23068886       2013       Virology
Result: Standard TAMs (M41L, D67N, L210W, F214L, T215F/Y, K219N/E), were observed in POL, with P1 lacking NRTI TAMs.


  Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy.
 PMID: 23079810       2013       AIDS (London, England)
Method: Thymidine analog mutations (TAMs) included M41L, D67N, K70R, L210W, T215F/Y, K219E/Q) that were further designated as TAM 1 (M41-L210-T215Y) or TAM 2 (D67-K70-T215F-K219).
Result: D67N and K219E were the TAMs seen with K65R in the three patients who had both.
Result: The two patients on TDF based regimens with a TAM mutation (K219E) also had the K65R mutation.


  Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.
 PMID: 23280237       2013       BMC infectious diseases
Result: The M184V reverse transcriptase mutation was detected in 80% of the sequenced RNA samples and tested positive in 74% and 47% by RNA-OLA and DNA-OLA, whereas thymidine associated mutations (TAMs: M41L, D67N, K70R, L210W, T215F/Y, K219Q/E) were detected in 50% of sequenced viral RNA.



Browser Board

 Co-occurred Entities




   Filtrator